# Use of Demineralised Bone Matrix (DBX) in Osteochondritis Dissecans (OCD)

> **NCT01283737** · PHASE4 · WITHDRAWN · sponsor: **Synthes GmbH**

## Conditions studied

- Osteochondritis Dissecans

## Interventions

- **DEVICE:** DBX Putty
- **PROCEDURE:** Mosaicplasty

## Key facts

- **NCT ID:** NCT01283737
- **Lead sponsor:** Synthes GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01283737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01283737, "Use of Demineralised Bone Matrix (DBX) in Osteochondritis Dissecans (OCD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01283737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*